Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

Daniel Weintraub, Nicole Dietz, John E. Duda, David A. Wolk, Jimit Doshi, Sharon X. Xie, Christos Davatzikos, Christopher M. Clark, Andrew Siderowf

Research output: Contribution to journalArticle

Abstract

Research suggests overlap in brain regions undergoing neurodegeneration in Parkinson's and Alzheimer's disease. To assess the clinical significance of this, we applied a validated Alzheimer's disease-spatial pattern of brain atrophy to patients with Parkinson's disease with a range of cognitive abilities to determine its association with cognitive performance and decline. At baseline, 84 subjects received structural magnetic resonance imaging brain scans and completed the Dementia Rating Scale-2, and new robust and expanded Dementia Rating Scale-2 norms were applied to cognitively classify participants. Fifty-nine non-demented subjects were assessed annually with the Dementia Rating Scale-2 for two additional years. Magnetic resonance imaging scans were quantified using both a region of interest approach and voxel-based morphometry analysis, and a method for quantifying the presence of an Alzheimer's disease spatial pattern of brain atrophy was applied to each scan. In multivariate models, higher Alzheimer's disease pattern of atrophy score was associated with worse global cognitive performance (β=-0.31, P=0.007), including in non-demented patients (β=-0.28, P=0.05). In linear mixed model analyses, higher baseline Alzheimer's disease pattern of atrophy score predicted long-term global cognitive decline in non-demented patients [F(1,110)=9.72, P=0.002], remarkably even in those with normal cognition at baseline [F(1,80)=4.71, P=0.03]. In contrast, in cross-sectional and longitudinal analyses there was no association between region of interest brain volumes and cognitive performance in patients with Parkinson's disease with normal cognition. These findings support involvement of the hippocampus and parietal-temporal cortex with cognitive impairment and long-term decline in Parkinson's disease. In addition, an Alzheimer's disease pattern of brain atrophy may be a preclinical biomarker of cognitive decline in Parkinson's disease.

Original languageEnglish (US)
Pages (from-to)170-180
Number of pages11
JournalBrain
Volume135
Issue number1
DOIs
StatePublished - 2012
Externally publishedYes

Fingerprint

Atrophy
Parkinson Disease
Alzheimer Disease
Brain
Dementia
Cognition
Magnetic Resonance Imaging
Parietal Lobe
Aptitude
Temporal Lobe
Cognitive Dysfunction
Linear Models
Hippocampus
Cross-Sectional Studies
Biomarkers
Research

Keywords

  • Alzheimer's disease
  • dementia
  • mild cognitive impairment
  • neurodegeneration
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Weintraub, D., Dietz, N., Duda, J. E., Wolk, D. A., Doshi, J., Xie, S. X., ... Siderowf, A. (2012). Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain, 135(1), 170-180. https://doi.org/10.1093/brain/awr277

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. / Weintraub, Daniel; Dietz, Nicole; Duda, John E.; Wolk, David A.; Doshi, Jimit; Xie, Sharon X.; Davatzikos, Christos; Clark, Christopher M.; Siderowf, Andrew.

In: Brain, Vol. 135, No. 1, 2012, p. 170-180.

Research output: Contribution to journalArticle

Weintraub, D, Dietz, N, Duda, JE, Wolk, DA, Doshi, J, Xie, SX, Davatzikos, C, Clark, CM & Siderowf, A 2012, 'Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease', Brain, vol. 135, no. 1, pp. 170-180. https://doi.org/10.1093/brain/awr277
Weintraub, Daniel ; Dietz, Nicole ; Duda, John E. ; Wolk, David A. ; Doshi, Jimit ; Xie, Sharon X. ; Davatzikos, Christos ; Clark, Christopher M. ; Siderowf, Andrew. / Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. In: Brain. 2012 ; Vol. 135, No. 1. pp. 170-180.
@article{6976d4dbbe6f4f0da0292634a0c8a6a1,
title = "Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease",
abstract = "Research suggests overlap in brain regions undergoing neurodegeneration in Parkinson's and Alzheimer's disease. To assess the clinical significance of this, we applied a validated Alzheimer's disease-spatial pattern of brain atrophy to patients with Parkinson's disease with a range of cognitive abilities to determine its association with cognitive performance and decline. At baseline, 84 subjects received structural magnetic resonance imaging brain scans and completed the Dementia Rating Scale-2, and new robust and expanded Dementia Rating Scale-2 norms were applied to cognitively classify participants. Fifty-nine non-demented subjects were assessed annually with the Dementia Rating Scale-2 for two additional years. Magnetic resonance imaging scans were quantified using both a region of interest approach and voxel-based morphometry analysis, and a method for quantifying the presence of an Alzheimer's disease spatial pattern of brain atrophy was applied to each scan. In multivariate models, higher Alzheimer's disease pattern of atrophy score was associated with worse global cognitive performance (β=-0.31, P=0.007), including in non-demented patients (β=-0.28, P=0.05). In linear mixed model analyses, higher baseline Alzheimer's disease pattern of atrophy score predicted long-term global cognitive decline in non-demented patients [F(1,110)=9.72, P=0.002], remarkably even in those with normal cognition at baseline [F(1,80)=4.71, P=0.03]. In contrast, in cross-sectional and longitudinal analyses there was no association between region of interest brain volumes and cognitive performance in patients with Parkinson's disease with normal cognition. These findings support involvement of the hippocampus and parietal-temporal cortex with cognitive impairment and long-term decline in Parkinson's disease. In addition, an Alzheimer's disease pattern of brain atrophy may be a preclinical biomarker of cognitive decline in Parkinson's disease.",
keywords = "Alzheimer's disease, dementia, mild cognitive impairment, neurodegeneration, Parkinson's disease",
author = "Daniel Weintraub and Nicole Dietz and Duda, {John E.} and Wolk, {David A.} and Jimit Doshi and Xie, {Sharon X.} and Christos Davatzikos and Clark, {Christopher M.} and Andrew Siderowf",
year = "2012",
doi = "10.1093/brain/awr277",
language = "English (US)",
volume = "135",
pages = "170--180",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

AU - Weintraub, Daniel

AU - Dietz, Nicole

AU - Duda, John E.

AU - Wolk, David A.

AU - Doshi, Jimit

AU - Xie, Sharon X.

AU - Davatzikos, Christos

AU - Clark, Christopher M.

AU - Siderowf, Andrew

PY - 2012

Y1 - 2012

N2 - Research suggests overlap in brain regions undergoing neurodegeneration in Parkinson's and Alzheimer's disease. To assess the clinical significance of this, we applied a validated Alzheimer's disease-spatial pattern of brain atrophy to patients with Parkinson's disease with a range of cognitive abilities to determine its association with cognitive performance and decline. At baseline, 84 subjects received structural magnetic resonance imaging brain scans and completed the Dementia Rating Scale-2, and new robust and expanded Dementia Rating Scale-2 norms were applied to cognitively classify participants. Fifty-nine non-demented subjects were assessed annually with the Dementia Rating Scale-2 for two additional years. Magnetic resonance imaging scans were quantified using both a region of interest approach and voxel-based morphometry analysis, and a method for quantifying the presence of an Alzheimer's disease spatial pattern of brain atrophy was applied to each scan. In multivariate models, higher Alzheimer's disease pattern of atrophy score was associated with worse global cognitive performance (β=-0.31, P=0.007), including in non-demented patients (β=-0.28, P=0.05). In linear mixed model analyses, higher baseline Alzheimer's disease pattern of atrophy score predicted long-term global cognitive decline in non-demented patients [F(1,110)=9.72, P=0.002], remarkably even in those with normal cognition at baseline [F(1,80)=4.71, P=0.03]. In contrast, in cross-sectional and longitudinal analyses there was no association between region of interest brain volumes and cognitive performance in patients with Parkinson's disease with normal cognition. These findings support involvement of the hippocampus and parietal-temporal cortex with cognitive impairment and long-term decline in Parkinson's disease. In addition, an Alzheimer's disease pattern of brain atrophy may be a preclinical biomarker of cognitive decline in Parkinson's disease.

AB - Research suggests overlap in brain regions undergoing neurodegeneration in Parkinson's and Alzheimer's disease. To assess the clinical significance of this, we applied a validated Alzheimer's disease-spatial pattern of brain atrophy to patients with Parkinson's disease with a range of cognitive abilities to determine its association with cognitive performance and decline. At baseline, 84 subjects received structural magnetic resonance imaging brain scans and completed the Dementia Rating Scale-2, and new robust and expanded Dementia Rating Scale-2 norms were applied to cognitively classify participants. Fifty-nine non-demented subjects were assessed annually with the Dementia Rating Scale-2 for two additional years. Magnetic resonance imaging scans were quantified using both a region of interest approach and voxel-based morphometry analysis, and a method for quantifying the presence of an Alzheimer's disease spatial pattern of brain atrophy was applied to each scan. In multivariate models, higher Alzheimer's disease pattern of atrophy score was associated with worse global cognitive performance (β=-0.31, P=0.007), including in non-demented patients (β=-0.28, P=0.05). In linear mixed model analyses, higher baseline Alzheimer's disease pattern of atrophy score predicted long-term global cognitive decline in non-demented patients [F(1,110)=9.72, P=0.002], remarkably even in those with normal cognition at baseline [F(1,80)=4.71, P=0.03]. In contrast, in cross-sectional and longitudinal analyses there was no association between region of interest brain volumes and cognitive performance in patients with Parkinson's disease with normal cognition. These findings support involvement of the hippocampus and parietal-temporal cortex with cognitive impairment and long-term decline in Parkinson's disease. In addition, an Alzheimer's disease pattern of brain atrophy may be a preclinical biomarker of cognitive decline in Parkinson's disease.

KW - Alzheimer's disease

KW - dementia

KW - mild cognitive impairment

KW - neurodegeneration

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=84856704601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856704601&partnerID=8YFLogxK

U2 - 10.1093/brain/awr277

DO - 10.1093/brain/awr277

M3 - Article

VL - 135

SP - 170

EP - 180

JO - Brain

JF - Brain

SN - 0006-8950

IS - 1

ER -